首页
400-620-6333
小分子和化合物库
选项
-
Mafosfamide Sodium SaltCAS号: 84211-05-2分子式: C9H18Cl2N2NaO5PS2 分子量: 423.25IUPAC Name: 2-[[2-[bis(2-chloroethyl)amino]-2-oxo-1,3,2λ5-oxazaphosphinan-4-yl]sulfanyl]ethanesulfonic acidSMILES: C1COP(=O)(NC1SCCS(=O)(=O)O)N(CCCl)CCClInChIKey: PBUUPFTVAPUWDE-UHFFFAOYSA-NInChI: 1S/C9H19Cl2N2O5PS2/c10-2-4-13(5-3-11)19(14)12-9(1-6-18-19)20-7-8-21(15,16)17/h9H,1-8H2,(H,12,14)(H,15,16,17)
-
D-葡萄糖-¹³C₆,1,2,3,4,5,6,6-d₇CAS号: 201417-01-8分子式: 13C6H5D7O6 分子量: 193.15IUPAC Name: (2R,3S,4R,5R)-1,2,3,4,5,6,6-heptadeuterio-2,3,4,5,6-pentahydroxy(1,2,3,4,5,6-13C6)hexan-1-oneSMILES: C(C(C(C(C(C=O)O)O)O)O)OInChIKey: GZCGUPFRVQAUEE-VVZLUFAVSA-NInChI: 1S/C6H12O6/c7-1-3(9)5(11)6(12)4(10)2-8/h1,3-6,8-12H,2H2/t3-,4+,5+,6+/m0/s1/i1+1D,2+1D2,3+1D,4+1D,5+1D,6+1D
-
L-丝氨酸-¹³C₃,¹⁵NCAS号: 202407-34-9 Compound CID : 71310240分子式: (¹³C)₃H₇(₁₅N)O₃ 分子量: 109.06SMILES: [13CH2]([C@@H]([13C](=O)O)[15NH2])O
-
L-天冬氨酸-¹³C₄,¹⁵NCAS号: 202468-27-7分子式: HO213C13CH213CH(15NH2)13CO2H 分子量: 138.07IUPAC Name: (2S)-2-(15N)azanyl(1,2,3,4-13C4)butanedioic acidSMILES: C(C(C(=O)O)N)C(=O)OInChIKey: CKLJMWTZIZZHCS-NYTNKSBQSA-NInChI: 1S/C4H7NO4/c5-2(4(8)9)1-3(6)7/h2H,1,5H2,(H,6,7)(H,8,9)/t2-/m0/s1/i1+1,2+1,3+1,4+1,5+1
-
Belantamab mafodotin (anti-BCMA)关联靶标: TNFRSF17简短描述: Purity≥90% (SDS-PAGE&SEC-HPLC); Endotoxin Level<1.0 EU/mg; Human IgG1; CHO; ELISA, Flow Cytometry, Functional assay, Animal Model; Conjugated (MC-VC-PAB-MMAF)种属反应性: 人(Human), 食蟹猴(Cynomolgus monkey) 亚型: Human IgG1宿主种属: 人(Human) 偶联: MC-VC-PAB-MMAFCAS号: 2050232-20-5SMILES: [Belantamab mafodotin]
-
Lifastuzumab vedotin (anti-SLC34A2)关联靶标: SLC34A2简短描述: Purity≥90% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Conjugated (MC-VC-PAB-MMAE)种属反应性: 人(Human) 亚型: Human IgG1宿主种属: 人(Human) 偶联: MC-VC-PAB-MMAECAS号: 1401812-88-1
-
Lorvotuzumab mertansine (anti-NCAM1)关联靶标: NCAM1简短描述: Purity>90% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Conjugated (SMCC-DM1)种属反应性: 人(Human) 亚型: Human IgG1宿主种属: 人(Human) 偶联: SMCC-DM1CAS号: 1008106-64-6
-
Lutikizumab (anti-IL1a&IL1b)简短描述: Purity≥90% (SDS-PAGE&SEC); Endotoxin Level≤1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated种属反应性: 人(Human), 小鼠(Mouse), 食蟹猴(Cynomolgus monkey) 亚型: Human IgG1宿主种属: 人(Human) 偶联: UnconjugatedCAS号: 1791411-57-8
-
Labetuzumab govitecan (anti-CEACAM5)关联靶标: CEACAM5简短描述: Purity>90% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Conjugated (CL2A-SN-38)种属反应性: 人(Human), 小鼠(Mouse), 食蟹猴(Cynomolgus monkey) 亚型: Human IgG1宿主种属: 人(Human) 偶联: CL2A-SN-38CAS号: 1469876-18-3 Compound CID : 91668184SMILES: See more
-
Ozoralizumab (anti-TNF-alpha&HSA)简短描述: Purity≥90% (SDS-PAGE&SEC); Endotoxin Level≤1.0EU/mg; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated种属反应性: 人(Human)宿主种属: 人(Human) 偶联: UnconjugatedCAS号: 1167985-17-2
-
Sacituzumab govitecan (anti-TROP2)关联靶标: TACSTD2简短描述: Purity≥90% (SDS-PAGE&SEC-HPLC); Endotoxin Level<1.0 EU/mg; Human IgG1; CHO; ELISA, Flow Cytometry, Functional assay, Animal Model; Conjugated (Mc-VC-PAB-SN38)种属反应性: 人(Human), 食蟹猴(Cynomolgus monkey) 亚型: Human IgG1宿主种属: 人(Human) 偶联: Mc-VC-PAB-SN38CAS号: 1491917-83-9SMILES: [Sacituzumab govitecan]
-
Blinatumomab (anti-CD3&CD19)简短描述: Purity≥90% (SDS-PAGE&SEC-HPLC); Endotoxin Level<1.0 EU/mg; CHO; ELISA, Flow Cytometry; Unconjugated种属反应性: 人(Human)宿主种属: 人(Human) 偶联: UnconjugatedCAS号: 853426-35-4
